HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
JNJ
Johnson & Johnson
Healthcare Drug Manufacturers - General · New Jersey, USA · Reports in usd
Market Cap: $625.39B
Market Cap
$625.39B
Enterprise Val
$653.67B
P/E Ratio
29.73
P/B Ratio
7.36
Trailing PEG (1Y)
As Of
Aug 10, 2026

Overview & Key Metrics

Reporting period: Jun 28, 2026 · Q2 2026
Book Value$84.97B
Gross Margin68.19%
Profit Margin68.19%
Return on Equity25.74%
Return on Assets10.60%
Current Ratio1.09
Debt/Equity0.58
LT Debt/Equity0.44
Revenue Per Share10.51

Income Statement

Jun 28, 2026
Revenue$25.31B
Cost of Revenue$8.05B
Gross Profit$17.26B
R&D$3.65B
SG&A$6.43B
Operating Expenses$10.12B
Operating Income$7.14B
Interest Expense$281.0M
Tax Expense$1.21B
Net Income$5.53B
EPS (Basic)$2.30
EPS (Diluted)$2.27
EBIT$7.03B
EBITDA$8.99B
Consolidated Income$5.53B
Non-Controlling Interests$0.00

Balance Sheet

Jun 28, 2026
Cash & Equivalents$20.42B
Accounts Receivable$19.05B
Inventory$15.14B
Current Assets$59.77B
LT Investments$0.00
Property, Plant & Equipment$23.58B
Intangibles$96.71B
Non-Current Assets$141.29B
Total Assets$201.06B
Accounts Payable$9.22B
Current Debt$11.69B
Current Liabilities$54.90B
LT Debt$37.34B
Non-Current Liabilities$61.20B
Total Liabilities$116.09B
Total Debt$49.04B
Retained Earnings$171.67B
Shareholder Equity$84.97B
Shares Outstanding2,407,216,971

Cash Flow Statement

Jun 28, 2026
Operating Cash Flow$8.62B
Investing Cash Flow-$1.11B
Financing Cash Flow-$8.78B
CapEx-$1.32B
Free Cash Flow$7.30B
Depreciation & Amort.$1.96B
Stock-Based Comp$458.0M
Acquisitions / Disposals-$200.0M
Investment Activity$550.0M
Debt Issued/Repaid-$5.69B
Equity Issued/Repaid$138.0M
Dividends Paid-$3.23B
Net Change in Cash-$1.27B
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h